Financials Nutex Health Inc. OTC Markets
Equities
NUTX
US67079U1088
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 USD | +2.01% | +6.77% | -89.69% |
09/05 | Earnings Flash (NUTX) NUTEX HEALTH Posts Q1 Revenue $67.5M | MT |
09/05 | Nutex Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 1,237 | 120.7 | 32.07 | - |
Enterprise Value (EV) 1 | 1,237 | 120.7 | 32.07 | 32.07 |
P/E ratio | -2.84 x | -2.57 x | -2.16 x | -4.31 x |
Yield | - | - | - | - |
Capitalization / Revenue | 5.64 x | 0.49 x | 0.11 x | 0.1 x |
EV / Revenue | 5.64 x | 0.49 x | 0.11 x | 0.1 x |
EV / EBITDA | 98.6 x | 11.2 x | 1.55 x | 1.01 x |
EV / FCF | 3,43,89,180 x | - | - | - |
FCF Yield | 0% | - | - | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 43,408 | 44,719 | 49,567 | - |
Reference price 2 | 28.50 | 2.700 | 0.6470 | 0.6470 |
Announcement Date | 02/03/23 | 28/03/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | 330.1 | 219.3 | 247.6 | 283.6 | 330 |
EBITDA 1 | - | 12.55 | 10.83 | 20.7 | 31.8 |
EBIT 1 | - | -4.578 | -1.292 | 9 | 13.8 |
Operating Margin | - | -2.09% | -0.52% | 3.17% | 4.18% |
Earnings before Tax (EBT) 1 | - | -419.6 | -48.49 | -5.5 | -0.2 |
Net income 1 | 132.6 | -424.8 | -45.79 | -11.1 | -7.2 |
Net margin | 40.17% | -193.7% | -18.49% | -3.91% | -2.18% |
EPS 2 | - | -10.05 | -1.050 | -0.3000 | -0.1500 |
Free Cash Flow | - | 35.97 | - | - | - |
FCF margin | - | 16.4% | - | - | - |
FCF Conversion (EBITDA) | - | 286.7% | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 16/06/22 | 02/03/23 | 28/03/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | 53.72 | 56.33 | 58.92 | 62.72 | 69.67 | 67.45 | 66.7 | 71.7 | 80.4 | 77.8 |
EBITDA 1 | - | -5.908 | 2.438 | 3.995 | 1.279 | 3.116 | 4.56 | 5.5 | 4.2 | 7.1 | 6.6 |
EBIT 1 | - | -5.779 | -4.228 | -0.3625 | -0.8212 | 4.077 | -1.151 | 2.2 | 1.4 | 4.8 | 2.1 |
Operating Margin | - | -10.76% | -7.51% | -0.62% | -1.31% | 5.85% | -1.71% | 3.3% | 1.95% | 5.97% | 2.7% |
Earnings before Tax (EBT) 1 | - | 1.478 | -7.833 | -5.082 | -4.866 | -30.71 | -0.1528 | -1.3 | -2.1 | 1.3 | -1.4 |
Net income 1 | -422.5 | -4.421 | -5.147 | -3.479 | -5.542 | -31.62 | -0.3641 | -2 | -3.6 | -2.1 | -2.3 |
Net margin | - | -8.23% | -9.14% | -5.9% | -8.84% | -45.38% | -0.54% | -3% | -5.02% | -2.61% | -2.96% |
EPS 2 | -9.750 | - | -0.1500 | -0.1500 | -0.1500 | -0.7500 | -0.0100 | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 22/11/22 | 02/03/23 | 15/05/23 | 09/08/23 | 09/11/23 | 28/03/24 | 08/05/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | 36 | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 16/06/22 | 02/03/23 | 28/03/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.92% | 81.04B | |
-29.48% | 68.93B | |
+9.65% | 29.59B | |
-0.14% | 17.24B | |
-9.30% | 16.99B | |
+0.20% | 15.12B | |
+5.25% | 13.09B | |
+68.96% | 12B | |
-2.88% | 11.94B |
- Stock Market
- Equities
- NUTX Stock
- NUTX Stock
- Financials Nutex Health Inc.